CAVALIERI, STEFANO
CAVALIERI, STEFANO
Dipartimento di Oncologia ed Emato-Oncologia
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management
2025 E. Colombo, M. Ducceschi, S. Cavalieri, M. Polignano, M. Bini, P. Ambrosini, M. De Monte, G. Montelatici, A. Russo, V. Bellia, S. Bhoori, C. Bergamini, S. Alfieri, I. Nuzzolese, A. Ottini, V. Mazzaferro, F. Raspagliesi, L. Licitra, M. Mantiero
The chemo-free approach for PDL1-positive platinum-sensitive recurrent/metastatic head and neck squamous cell carcinoma: Viable option or misguided myth?
2025 S. Cavalieri, N. Crippa, B. Lombardi Stocchetti, L. Licitra
Personalized treatment in HPV+ oropharynx cancer using genomic adjusted radiation dose
2025 E. Ho, L. De Cecco, S.A. Eschrich, S. Cavalieri, G. Sedor, F. Hoebers, R.H. Brakenhoff, K. Scheckenbach, T. Poli, K. Yang, J.A. Scarborough, S. Nellore, S. Campbell, N. Woody, T. Chan, J. Miller, N. Silver, S. Koyfman, J. Bates, J.J. Caudell, M.W. Kattan, L. Licitra, J.F. Torres-Roca, J.G. Scott
Transcriptomic based prognostic model versus TNM 9th edition in HPV-positive oropharyngeal cancer
2025 S. Cavalieri, R.H. Brakenhoff, C.R. Leemans, F. Hoebers, K. Scheckenbach, T.K. Hoffmann, D. Mattavelli, T. Poli, E. Orlandi, L. Licitra, L. De Cecco
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study
2025 E. Colombo, S. Cavalieri, A. Vingiani, L. Agnelli, M. Duca, B. Paolini, F. Perrone, E. Tamborini, I. Capone, A. Piccolo, F. Caspani, C. Bergamini, S. Alfieri, C. Resteghini, I. Nuzzolese, A. Ottini, S. Buriolla, M. Salvetti, G. Calareso, M. Milione, G. Pruneri, L.D. Locati, L. Licitra
The Host-index in patients undergoing upfront surgery and free flap reconstruction for head and neck squamous cell carcinoma
2025 V. Cristofaro, L. Giannini, A. Alliata, F. Fraccaroli, F. Incandela, M. Pompilio, S. Cavalieri, A. Deganello
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers
2025 F. Caspani, S. Cavalieri, E. Orlandi, C. Bergamini, C. Resteghini, E. Colombo, A. Ottini, I. Nuzzolese, S. Alfieri, A. Mirabile, A. Cassano, P. Bossi, T. Ibrahim, M.C. Cau, M. Ghiani, F. Bertolini, R. Ingargiola, G. Fontana, L. Licitra, L.D. Locati
Indirect comparison ofTPF and GP induction chemotherapy regimens in nasopharyngeal carcinoma: a data-driven reassessment before the transition to induction chemoimmunotherapy
2025 S. Cavalieri, A. Ottini, B.L. Stocchetti, L. Licitra
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial
2025 P. Bossi, A. Alberti, C. Bergamini, C. Resteghini, L.D. Locati, S. Alfieri, S. Cavalieri, E. Colombo, C. Gurizzan, L. Lorini, V. Tovazzi, M. Zamparini, M. Ravanelli, P.A. Ascierto, V. Rampinelli, A. Grammatica, R. Patuzzo, A. Maurichi, L.F. Licitra
The Role of Cetuximab in Non-Melanoma Skin Cancer: A Review of Clinical Evidence and Emerging Strategies
2025 I. Nuzzolese, S. Cavalieri, L.F. Licitra, S. Alfieri
Prognostic gene expression signatures for HPV-negative head and neck squamous cell carcinoma
2025 S. Cavalieri, R.H. Brakenhoff, C.R. Leemans, F.J.P. Hoebers, T. Poli, K. Scheckenbach, N.A. Iacovelli, M. Franceschini, E. Orlandi, L. Licitra, L. De Cecco
Systemic anticancer therapy during end of life in head and neck squamous cell carcinoma patients. A retrospective single center study
2025 S. Rota, S. Buriolla, A. Franza, S. Cavalieri, C. Bergamini, S. Alfieri, I. Nuzzolese, E. Colombo, A. Ottini, B. Lombardi Stocchetti, G. Massa, A. Caraceni, L. Licitra, C. Resteghini
Ferroptosis-Related Gene Signatures: Prognostic Role in HPV-Positive Oropharyngeal Squamous Cell Carcinoma
2025 D. Lenoci, M.S. Serafini, M. Lucchetta, S. Cavalieri, R.H. Brakenhoff, F. Hoebers, K. Scheckenbach, T. Poli, L. Licitra, L. De Cecco
Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma
2025 A. Corti, D. Lenoci, V.D.A. Corino, D. Mattavelli, M. Ravanelli, T. Poli, S. Cavalieri, L. Licitra, L. De Cecco, L. Mainardi
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA study
2025 S. Alfieri, R. Romano, S. Marceglia, C. Sciortino, W. Ferrari Bravo, M. Zucchini, M.L. Piscitelli, I. Nuzzolese, S. Cavalieri, C. Bergamini, E. Colombo, A. Ottini, L. De Cecco, D. Lenoci, N.A. Iacovelli, M. Guzzo, E. Orlandi, L.D. Locati, P. Bossi, L. Licitra, F. Taverna
Editorial: Diagnosis, epidemiology and treatment of salivary gland carcinomas
2024 I. Nuzzolese, P. Bonomo, E. Orlandi, A. Mock, S. Cavalieri
Quality of life in head and neck cancer survivors: the Big Data for Quality of Life study
2024 M. Moreira-Soares, E. Fossen, K. Taylor, S. Singer, K. Hurley, S. Thomas, M. Pring, A. Ness, S. Cavalieri, C. Vener, L. Lopez-Perez, M. Cabrera-Umpierrez, G. Fico, A. Frigessi, L. Licitra, M. Leblanc
HeNeCOn: An ontology for integrative research in Head and Neck cancer
2024 L. Hernández, E. Estévez-Priego, L. López-Pérez, M. Cabrera-Umpiérrez, M. Arredondo, G. Fico, T. Poli, S. Rossi, E. Martinelli, L. Licitra, S. Cavalieri, L. De Cecco, S. Canevari, K. Scheckenbach, R. Brakenhoff, I. Nauta, F. Hoebers, F. Wesseling, A. Trama, G. Gatta
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities
2024 D. Lenoci, C. Resteghini, M.S. Serafini, F. Pistore, S. Canevari, B. Ma, S. Cavalieri, S. Alfieri, A. Trama, L. Licitra, L. De Cecco
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/ metastatic head and neck squamous cell carcinoma treated with nivolumab
2024 M.S. Serafini, S. Cavalieri, L. Licitra, F. Pistore, D. Lenoci, S. Canevari, M. Airoldi, M.C. Rocca, P. Strojan, C.G. Kuhar, M. Merlano, F. Perrone, A. Vingiani, N. Denaro, F. Perri, A. Argiris, C. Gurizzan, M.G. Ghi, A. Cassano, G. Allegrini, P. Bossi, L. De Cecco